Latest The FASEB Journal Stories
Nutrition 21, LLC (“Nutrition 21”) is proud to announce the presentation of a new clinical study supporting Nitrosigine™ inositol-stabilized arginine silicate, titled, “A Clinical Evaluation
It's not a hair-brained idea: A new research report appearing in the April 2014 issue of The FASEB Journal explains why people with a rare balding condition called "atrichia with papular lesions" lose their hair, and it identifies a strategy for reversing this hair loss.
A new report published online in The FASEB Journal may lead the way toward new treatments or a cure for a common cause of blindness (proliferative retinopathies).
New research in the FASEB Journal suggests that consumption of dark chocolate lowers the augmentation index, a key vascular health predictor, and reduces adhesion of white blood cells to the vessel wall.
Scientists have moved a step closer to an "obesity drug" that may block the effects of diets high in sugar and fats.
It's not the little blue pill famous for helping men get big results, but for those who need it, the outcome might be even more significant.
If you are obese and hope to be a father, here's another reason to lose weight: your children and grandchildren may inherit your waistline or metabolic disorders.
Resolvins are molecules naturally produced by the body from omega-3 fatty acids – a process that can be jumpstarted by common aspirin.
With the remains of a recent lottery winner having been exhumed for foul play related to cyanide poisoning, future winners might wonder what they can do to avoid the same fate.
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a novel strategy for preventing infections due to the highly common herpes simplex viruses, the microbes responsible for causing genital herpes (herpes simplex virus 2) and cold sores (herpes simplex virus 1).